Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Compugen Ltd. Regulatory Filings 2005

Apr 4, 2005

6734_rns_2005-04-04_129e6d86-d9c2-43dc-a71e-13093cdca8be.htm

Regulatory Filings

Open in viewer

Opens in your device viewer

C002 �������� ��"� 2
Public COMPUGEN LTD.
2521 Corporation no: 511779639
Stock Exchange/Market: ��������
606
380 Pinchas Rosen 72 , Tel Aviv 69512 , ,
Tel: 03-7658585 , 03-7658525 Fax: 03-7658555
E.mail address: AYALA@COMPUGEN .CO.IL Date of transmission: 04/04/2005
Time of broadcast: 12:54 12:52:29
Reference: 2005-02-011952
Israel Securities Authority Tel Aviv Stock Exchange
www.isa.gov.il www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on Compugen Appoints Vice President, Computational Life Science Research and Development
6-KApril42005_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous name of reporting entity:
Date of revision of form structure: 20/01/2005
- - -
Name of the Signatory : Benjamini Nurit Position of Signatory in the reporting corporation: Chief Financial Officer
Pinchas Rosen Telephone: 03-7658525 , Facsimile: 03-7658516 , E-mail: [email protected]